The January 2013 merger of two innovative cardiovascular device companies – CardioLogical Solutions and Emboline Inc. – under the name promises to provide a one-stop shop for a full range of accessory devices to improve the safety and efficacy of transcatheter aortic valve implantation (TAVI) procedures performed by either an interventional cardiologist or a thoracic surgeon. [See Deal]
The aortic valve is located between the left ventricle and the aorta of the heart. The main indication for TAVI is the narrowing of the aortic value (aortic stenosis) that...